Validity of the Good Practice Guidelines: The example of type 2 diabetes

Area of Science:

• Clinical Practice Guidelines
• Evidence-Based Medicine
• Diabetes Mellitus Research

Background:

• Type 2 diabetes (T2D) management relies on Good Practice Guidelines (GPGs).
• Assessing the quality of these GPGs is crucial for effective T2D treatment.
• Methodological rigor in guideline development ensures reliable recommendations.

Purpose of the Study:

• To evaluate the methodological quality of systematic reviews informing T2D treatment GPGs.
• To identify deficiencies in the development and reporting of T2D GPGs.
• To assess the integration of high-level evidence, such as meta-analyses, into T2D guidelines.

Main Methods:

• Systematic search for T2D GPGs published from May 2012 onwards.
• Quality assessment using criteria: grading of evidence, strength of recommendations, systematic review statements, methods description, and citation of key meta-analyses.
• Inclusion of GPGs from major databases: PubMed, Guidelines International Network, National Guidelines Clearing House, and Infobanque des guides de pratique clinique.

Main Results:

• Fifty-two T2D GPGs were analyzed.
• Only 58% of GPGs reported conducting a systematic review.
• Half of the GPGs utilized grading systems; however, three-quarters failed to detail bibliographic search methods.
• Crucially, only one GPG cited the three relevant meta-analyses that challenged intensive glycemic control strategies.

Conclusions:

• The methodological quality of T2D GPGs is insufficient.
• Lack of detailed methods and citation of critical meta-analyses compromises the rigor of current T2D guidelines.
• Improved guideline development processes are needed to enhance evidence-based T2D treatment.